Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
INDP
Stock Latest News
Ratings
Positive Outlook for Indaptus Therapeutics Amid Promising Clinical Trial Advancements and Innovative Decoy20 Platform
12d ago
INDP
Premium
The Fly
Indaptus Therapeutics reports Q1 EPS (32c) vs. (45c) last year
13d ago
INDP
Premium
The Fly
Indaptus needs to obtain additional capital to fund activities beyond 2Q25
13d ago
INDP
Premium
The Fly
Indaptus Therapeutics reports new data on Phase 1 trial of Decoy20
2M ago
INDP
Premium
The Fly
Indaptus Therapeutics initiates Phase 1 study of Decoy20
2M ago
INDP
Premium
Ratings
Buy Recommendation for Indaptus Therapeutics: Promising Phase 1 Study and Financial Stability Boost Confidence
2M ago
INDP
Premium
The Fly
Indaptus Therapeutics reports FY24 EPS ($1.61) vs ($1.83) last year
3M ago
INDP
Premium
The Fly
Indaptus Therapeutics expands patent portfolio in China, Japan, Israel
3M ago
INDP
Premium
The Fly
Indaptus Therapeutics files to sell 10M shares of common stock for holders
3M ago
INDP
Premium
The Fly
Indaptus Therapeutics files to sell 4.37M shares of common stock for holders
4M ago
INDP
Premium
The Fly
Indaptus receives approval from Health Canada to expand trial of Decoy20
4M ago
INDP
Premium
The Fly
Indaptus Therapeutics announces anticipated milestones in 1H of 2025
5M ago
INDP
Premium
The Fly
Indaptus Therapeutics files to sell 1.94M shares of common stock for holders
5M ago
INDP
Premium
The Fly
Indaptus to sell 1.82M shares at $1.175 in registered direct offering
6M ago
INDP
Premium
The Fly
Indaptus Therapeutics price target lowered to $5 from $8 at Maxim
7M ago
INDP
Premium
The Fly
Indaptus Therapeutics reports Q3 EPS (32c) vs. (47c) last year
7M ago
INDP
Premium
The Fly
Indaptus Therapeutics sees cash runway into 1Q25
7M ago
INDP
Premium
The Fly
Indaptus Therapeutics publishes research in Frontiers in Immunology
7M ago
INDP
Premium
The Fly
Indaptus Therapeutics completes safety, PK, biomarker data on Decoy20
7M ago
INDP
Premium
The Fly
Indaptus Therapeutics announces clinical supply agreement with BeiGene
7M ago
BGNE
INDP
Premium
The Fly
Indaptus initiates unrestricted enrollment on patients on Decoy20 weekly dosing
7M ago
INDP
Premium
The Fly
Indaptus Therapeutics CSO to speak on webinar about cancer immunotherapy
8M ago
INDP
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
